The Small Animal Cancer Imaging Research Facility (SACIRF) provides cancer investigators with the latesttechnology and techniques for experimental in vivo imaging of small animals. The facility includes state-ofthe-art instrumentation, including the modalities of magnetic resonance (MR, Bruker4.7 T, 40 cm Biospec),x-ray computed tomography (micro-CT from Enhanced Vision Systems and volume CT being developed incollaboration with General Electric), projection radiography (Faxitron), and nuclear imaging (M.Cam gammacamera from Siemens and micro-PET from Concorde Microsystems). Optical imaging will be added duringthe first year of the award (instrumentation to be developed in collaboration with Biomedical Engineering atThe University of Texas-Austin). This instrumentation represents a >$3M investment by MDACC. TheSACIRF has allocated space for the instruments in the animal support facilities to facilitate the inclusion ofthe imaging studies in ongoing cancer research, and dedicated office and developmental laboratory space tosupport the facility operation. The faculty and staff are well-qualified in each of the modality areas, includingcurrent image acquisition and image analysis techniques. Specialty areas include quantitative tissuecharacterization (MR), imaging of microvascular physiology (MR, nuclear, CT and optical), diffusion imagingfor estimating cellular density (MR), metabolic imaging (nuclear, positron emission tomography [PET], opticaland MR spectroscopy), and vascular imaging (MR, CT, and x-ray). The services of the facility includeimaging protocol design, custom positioning systems, custom data acquisition hardware and software, imageanalysis, data archiving, provision of hardcopy and digital data delivery, and database maintenance. TheVeterinary Core includes a dedicated support team that provides highly efficient imaging studies and a verylow mortality rate of animals during the imaging procedures. Services provided from the Veterinary Coreinclude development of veterinary support protocols specific to each experimental design, and consultationon the inclusion of imaging procedures into existing protocols to obtain Institutional Animal Care and UseCommittee approval. To date, 75 investigators representing 13 programs have used facility instrumentation.42% of the users are peer-review-funded investigators. Utilization continues to increase as the facility and itscapabilities become better known to the local cancer research community. The capabilities of the facilitycontinue to grow to meet experimental demands. Publications are evolving at a rapid pace, and althoughonly a few are published, the acceptance rate has been nearly 100%. Funding for the SACIRF is currentlyCCSG (43%), user fees (36%), and MDACC (21%).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016672-33
Application #
7695936
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-08-28
Project End
2013-06-30
Budget Start
2008-08-28
Budget End
2009-06-30
Support Year
33
Fiscal Year
2008
Total Cost
$161,106
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Boddu, Prajwal; Masarova, Lucia; Verstovsek, Srdan et al. (2018) Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms. Ann Hematol 97:109-121
Casasent, Anna K; Schalck, Aislyn; Gao, Ruli et al. (2018) Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing. Cell 172:205-217.e12
Noh, Hyangsoon; Zhao, Qingnan; Yan, Jun et al. (2018) Cell surface vimentin-targeted monoclonal antibody 86C increases sensitivity to temozolomide in glioma stem cells. Cancer Lett 433:176-185
Hutcheson, Katherine A; Barrow, Martha P; Plowman, Emily K et al. (2018) Expiratory muscle strength training for radiation-associated aspiration after head and neck cancer: A case series. Laryngoscope 128:1044-1051
Zhao, Jun; Xiao, Zhilan; Li, Tingting et al. (2018) Stromal Modulation Reverses Primary Resistance to Immune Checkpoint Blockade in Pancreatic Cancer. ACS Nano 12:9881-9893
Akhtari, Mani; Milgrom, Sarah A; Pinnix, Chelsea C et al. (2018) Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation. Blood 131:84-94
Barua, Souptik; Solis, Luisa; Parra, Edwin Roger et al. (2018) A Functional Spatial Analysis Platform for Discovery of Immunological Interactions Predictive of Low-Grade to High-Grade Transition of Pancreatic Intraductal Papillary Mucinous Neoplasms. Cancer Inform 17:1176935118782880
Ma, Junsheng; Chan, Wenyaw; Tilley, Barbara C (2018) Continuous time Markov chain approaches for analyzing transtheoretical models of health behavioral change: A case study and comparison of model estimations. Stat Methods Med Res 27:593-607
Bayraktar, Recep; Ivan, Cristina; Bayraktar, Emine et al. (2018) Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion. Clin Cancer Res 24:4225-4241
Parra, Edwin R; Villalobos, Pamela; Mino, Barbara et al. (2018) Comparison of Different Antibody Clones for Immunohistochemistry Detection of Programmed Cell Death Ligand 1 (PD-L1) on Non-Small Cell Lung Carcinoma. Appl Immunohistochem Mol Morphol 26:83-93

Showing the most recent 10 out of 12418 publications